Activin, a member of the transforming growth factor-beta superfamily,
binds to two classes of cell surface receptors. These receptors, desig
nated type I and type II, are structurally related members of transmem
brane serine kinase superfamily. Antibodies specific for either type I
or type II activin receptor can coprecipitate complexes containing bo
th affinity-labeled receptors from activin-responsive cells. Two type
I receptors show cell-specific expression and associate with the ligan
d-binding, type II receptors. To investigate the roles of the cytoplas
mic receptor domains in signaling through a heteromeric ligand recepto
r complex, we have made kinase-deficient activin receptors and correla
ted their losses in kinase activity with inhibitory effects on an acti
vin-dependent transcriptional response in activin-responsive cell line
s. Wild-type activin type II receptors phosphorylate activin type I re
ceptors in transfected COS cells. In contrast, kinase-deficient activi
n type II receptors fail to phosphorylate type I receptors in transfec
ted COS cells and act as dominant negative mutants to block activin-in
duced transcriptional activity in both Chinese hamster ovary and K562
(human erythroleukemia) cells. Kinase-deficient activin type IB recept
ors also block activin-induced transcriptional activity in both Chines
e hamster ovary and K562 cells, whereas kinase-deficient activin type
I receptors have no effect in either cell line. These results indicate
that kinase activities of both type II and type I receptors are requi
red for activin signaling, and that the two type I receptors, which ar
e expressed in a tissue-specific manner, are functionally distinct.